Institutional Ownership Terns Pharmaceuticals, Inc. (TERN)
This table provides information about the institutional ownership of Terns Pharmaceuticals, Inc. (TERN). We have compiled data on the 160 institutions that hold shares in the stock, with a total of 83.9 Million shares, which have been reported (via 13F filing form) to have a value of $285 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
8,142,500
shares
|
$27.7 Million
3.16% of portfolio
|
Q4 2024
Added 30.83%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
7,562,971
shares
|
$25.7 Million
1.14% of portfolio
|
Q3 2024
Reduced 0.74%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
Feb 13, 2025 Q4 2024 |
6,895,746
shares
|
$23.4 Million
7.51% of portfolio
|
Q3 2024
Added 11.53%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
5,576,558
shares
|
$19 Million
1.37% of portfolio
|
Q3 2024
Reduced 8.58%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
4,751,506
shares
|
$16.2 Million
0.17% of portfolio
|
Q4 2024
Added 44.43%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,120,508
shares
|
$14 Million
0.0% of portfolio
|
Q2 2024
Added 24.28%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
3,869,582
shares
|
$13.2 Million
0.0% of portfolio
|
Q4 2024
Added 15.28%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
3,347,807
shares
|
$11.4 Million
0.0% of portfolio
|
Q4 2024
Added 327.6%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
3,267,779
shares
|
$11.1 Million
0.0% of portfolio
|
Q4 2024
Reduced 11.04%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
2,633,918
shares
|
$8.96 Million
0.0% of portfolio
|
Q4 2024
Added 30.59%
|
|
|
Candriam S.C.A.
|
Feb 06, 2025 Q4 2024 |
2,153,969
shares
|
$7.32 Million
0.07% of portfolio
|
Q4 2024
New holding
|
|
|
Superstring Capital Management LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,020,562
shares
|
$6.87 Million
9.69% of portfolio
|
Q4 2024
Added 49.83%
|
|
|
Acorn Capital Advisors, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,971,264
shares
|
$6.7 Million
5.9% of portfolio
|
Q4 2024
New holding
|
|
|
Driehaus Capital Management LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,661,846
shares
|
$5.65 Million
0.09% of portfolio
|
Q4 2024
Reduced 20.55%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
1,610,215
shares
|
$5.47 Million
0.0% of portfolio
|
Q4 2024
Added 2.01%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,516,478
shares
|
$5.16 Million
0.0% of portfolio
|
Q4 2024
Added 25.59%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,504,238
shares
|
$5.11 Million
0.0% of portfolio
|
Q4 2024
Added 1.94%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
1,302,932
shares
|
$4.43 Million
0.0% of portfolio
|
Q4 2024
Added 107.02%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,287,043
shares
|
$4.38 Million
0.0% of portfolio
|
Q4 2024
Added 15.22%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Feb 14, 2025 Q4 2024 |
1,251,841
shares
|
$4.26 Million
0.02% of portfolio
|
Q4 2024
Reduced 53.76%
|
|
|
Vr Adviser, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,077,090
shares
|
$3.66 Million
0.99% of portfolio
|
Q4 2024
Reduced 68.41%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Feb 14, 2025 Q4 2024 |
1,061,753
shares
|
$3.61 Million
0.12% of portfolio
|
Q4 2024
Added 1.88%
|
|
|
Norges Bank
Oslo, Q8 |
Feb 12, 2025 Q4 2024 |
849,389
shares
|
$2.89 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Feb 14, 2025 Q4 2024 |
829,105
shares
|
$2.82 Million
0.67% of portfolio
|
Q4 2024
Added 51.92%
|
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
803,336
shares
|
$2.73 Million
0.01% of portfolio
|
Q4 2024
Added 666.85%
|